Overview

Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation

Status:
Unknown status
Trial end date:
2020-12-23
Target enrollment:
Participant gender:
Summary
The study evaluate the absorption rate of different sublingual formulation of nitroglycerine (NTG) either in the form of available tablets or a new rapid absorbable gelation capsule formulation "NTG1523" by determining T-max and area under the response curve of nitoglycerine in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project
Phase:
Phase 4
Details
Lead Sponsor:
Kolding Sygehus
Treatments:
Nitroglycerin